Sort
51,593 grants matching “hepatitis”
Apo E mimetics reduce cholesterol and improve HDL function
$412,969G M Anantharamaiah · University Of Alabama At Birmingham · R01 · FY2011 · HL
IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION
$412,949Donald A. McClain · University Of Utah · R01 · FY2012 · DK
INBRE: WINTHROP U: FACULTY & UNDERGRADUATE RESEARCH DEVELOPMENT
$412,942Patrick Owens · University Of South Carolina At Columbia · P20 · FY2009 · RR
The budding yeast endocytic pathway
$412,938David G. Drubin · University Of California Berkeley · R01 · FY2014 · GM
Synthesis: HCV Epidemiology and Prevention in Drug Users
$412,934Holly C. Hagan · National Development And Research Institutes, Inc. · R01 · FY2006 · DA
Adenovirus-host interactions and in vivo virus targeting
$412,933Dmitry Shayakhmetov · University Of Washington · R01 · FY2012 · CA
MOLECULAR PATHOGENESIS OF HEPATOCELLULAR CARCINOMA
$412,916Scripps Research Institute · R01 · FY2003 · CA
TRAINING IN PEDIATRIC GASTROENTEROLOGY AND NUTRITION
$412,869Wayne Lencer · Boston Children'S Hospital · T32 · FY2011 · DK
Drug Therapies Identified through Modeling AT Deficiency in C Elegans
$412,864Gary Arthur Silverman · Washington University · P01 · FY2021 · DK
Control of hepatic T cell responses in biliary atresia
$412,863Alexander Miethke · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK
Control of hepatic T cell responses in biliary atresia
$412,863Alexander Miethke · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
Control of hepatic T cell responses in biliary atresia
$412,863Alexander Miethke · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Control of hepatic T cell responses in biliary atresia
$412,863Alexander Miethke · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Role of Insulin Biosynthesis in Glucose Tolerance
$412,805Daniel T Stein · Albert Einstein College Of Medicine · R01 · FY2012 · DK
IGFBP1 mediates a liver-bone-muscle axis in colorectal cancer cachexia
$412,676Andrea Bonetto · University Of Colorado Denver · R01 · FY2022 · AR
Role of PDZK1 in lipid metabolism and atherosclerosis.
$412,675Olivier N. Kocher · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL
Role of PDZK1 in lipid metabolism and atherosclerosis.
$412,675Olivier N. Kocher · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Role of PDZK1 in lipid metabolism and atherosclerosis.
$412,675Olivier N. Kocher · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
Perinatal Mechanisms of Detoxification
$412,634Eric F Johnson · Scripps Research Institute, The · R01 · FY2011 · HD
Impact of HIV PMTCT Interventions on HIV/HBV Co-infected Women and Their Infants
$412,630Debika Bhattacharya · University Of California Los Angeles · R01 · FY2018 · HD
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
$412,617John D Groopman · Johns Hopkins University · P01 · FY2010 · ES
Structural Basis of APOBEC Functions and HIV Restriction
$412,607Xiaojiang S Chen · University Of Southern California · R01 · FY2024 · AI
PATHOBIOLOGY OF HEPATIC EPITHELIA
$412,603Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · DK
Structural Basis of APOBEC Functions and HIV Restriction
$412,602Xiaojiang S Chen · University Of Southern California · R01 · FY2022 · AI
New Congenital Disorders of Glycosylation: Therapy and Models
$412,576Hudson H Freeze · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK